Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese women

Metabolism: Clinical and Experimental

Volumn 53, Issue 3, 2004, Pages 280-283

  Abbasi, Fahim ^b   Lamendola, Cindy ^b   McLaughlin, Tracey ^b   Hayden, John ^b   Reaven, Gerald M ^a   Reaven, Peter D ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; OCTREOTIDE; SIBUTRAMINE; PROTEIN; SIGNAL PEPTIDE;

ADULT; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; OBESITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; STEADY STATE; WEIGHT REDUCTION; BLOOD; BODY MASS; CLINICAL TRIAL; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; OBESITY; PROTEINS; WEIGHT LOSS;

EID: 2542469639     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2003.10.004     Document Type: Article

References (26)

1. Arita Y, Kihara S, Ouchi N, et al: Paradoxical decrease of an adipose-tissue specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83, 1999
2. Weyer C, Funahashi T, Tanaka S, et al: Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935, 2001
3. Berg AH, Combs TP, Scherer PE: ACRP30/adiponectin: An adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 13:84-89, 2002
4. Yamamoto Y, Hirose H, Saito I, et al: Correlation of the adipocyte-derived protein adiponectin with insulin resistance and serum high-density lipoprotein cholesterol, independent of body mass index in the Japanese population. Clin Sci (Lond) 103:137-142, 2002
5. Tschritter O, Fritsche A, Thamer C, et al: Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes 52:239-243, 2003
6. Yang W-S, Lee W-J, Funahashi T, et al: Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86:3815-3819, 2001
7. Hulver MW, Zheng D, Tanner CJ, et al: Adioponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol 283:E861-E865, 2002
8. , Faraj M, Havel PJ, Phelis S, et al: Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. J Clin Endocrinol Metab 88:1594-1602, 2003
9. Guldstrand M, Ahren B, Adamson U: Improved beta-cell function after standardized weight reduction in severely obese subjects. Am J Physiol 284:E557-E565, 2003
10. Esposito K, Pontillo A, Di Palo C, et al: Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women. A randomized trial. JAMA 289:1799-1784, 2003
11. Olefsky J, Reaven GM, Farquhar JW: Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects. J Clin Invest 53:64-76, 1974
12. Ferrannini E, Natali A, Bell P, et al, on behalf of the European Group for the Study of insulin Resistance (EGIR): Insulin resistance and hypersecretion in obesity. J Clin Invest 100:1166-1173, 1997
13. Jones CN, Abbasi F, Carantoni M, et al: Roles of insulin resistance and obesity in regulation of plasma insulin concentrations. Am J Physiol 278:E501-508, 2000
14. McLaughlin T, Abbasi F, Carantoni, et al: Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women. J Clin Endocrinol Metab 84:578-81, 1999
15. McLaughlin T, Abbasi F, Kim H-S, et al: Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women. Metabolism 50:795-800, 2001
16. McLaughlin T, Abbasi F, Lamendola C, et al: Differentiation between obesity and insulin resistance in the association with C-reactive protein, Circulation 106:2908-2912, 2002
17. Abbasi F, Chu J, McLaughlin T, et al: Obesity versus insulin resistance in modulation of plasma adiponectin concentrations. Diabetes 52:A81, 2003 (suppl 1, abstr)
18. Shen SW, Reaven GM, Farquhar JW: Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes, J Clin Invest 49:2151-2160, 1970
19. Greenfield MS, Doberne L, Kraemer F, et al: Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp. Diabetes 30:387-392, 1981
20. Pei D, Jones CN, Bhargava R, et al: Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test. Diabetologia 37:843-845, 1994
21. Yeni-Komshian H, Carantoni M, Abbasi F, et al: Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy, nondiabetic volunteers. Diabetes Care 23:171-175, 2000
22. Xydakis A, Case C, Jones P, et al: The hormonal impact of weight loss in obese patients with the metabolic syndrome. Diabetes 52:A396, 2003 (suppl 1, abstr)
23. Fasshauer M, Klein J, Neumann S, et al: Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 290:1084-1089, 2002
24. Yu JG, Javorschi S, Hevener AL, et al: The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 51:2968-2974, 2002
25. Motoshima H, Wu X, Sinha MK, et al: Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: Effects of insulin and rosiglitazone. J Clin Endocrinol Metab 87:5662-5667, 2002
26. Yamauchi T, Kamon J, Ito Y, et al: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762-769, 2003